- Report
- April 2024
- 30 Pages
Global
From €2847EUR$3,250USD£2,457GBP
- Report
- April 2024
- 30 Pages
Global
From €2409EUR$2,750USD£2,079GBP
- Report
- January 2024
- 145 Pages
Global
From €6965EUR$7,950USD£6,011GBP
- Drug Pipelines
- January 2024
- 136 Pages
Global
From €6571EUR$7,500USD£5,670GBP
- Report
- August 2022
- 218 Pages
Global
From €6571EUR$7,500USD£5,670GBP
- Report
- August 2022
- 109 Pages
Global
From €3461EUR$3,950USD£2,986GBP
- Report
- January 2022
- 60 Pages
Global
From €3461EUR$3,950USD£2,986GBP
- Report
- October 2025
- 8 Pages
United States
- Report
- September 2025
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 88 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 88 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2025
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- August 2025
- 86 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- July 2025
- 85 Pages
Brazil
From €3066EUR$3,500USD£2,646GBP
- Report
- December 2024
- 70 Pages
India
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2024
- 82 Pages
Japan
From €3066EUR$3,500USD£2,646GBP
- Report
- September 2024
- 181 Pages
Global
From €3943EUR$4,500USD£3,402GBP

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics.
The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more